YEAR
- 2013.12.04 The orally available Btk inhibitor ibrutinib (PCI-32765) protects against osteoclast-mediated bone loss. Shinohara M, Chang BY, Buggy JJ, Nagai Y, Kodama T, Asahara H, Takayanagi H.Bone. 2014 Mar;60:8-15. doi: 10.1016/j.bone.2013.11.025
- 2013.12.03 Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, Ikushima H, Onoe T, Ohdan H, Yoshida N, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2013 Dec 17;110(51):20699-704. doi: 10.1073/pnas.1320808110
- 2013.11.26 H3F3A K27M mutations in thalamic gliomas from young adult patients. Aihara K, Mukasa A, Gotoh K, Saito K, Nagae G, Tsuji S, Tatsuno K, Yamamoto S, Takayanagi S, Narita Y, Shibui S, Aburatani H, Saito N.Neuro-oncology. 2014 Jan;16(1):140-6. doi: 10.1093/neuonc/not144
- 2013.11.18 Beneficial innate signaling interference for antibacterial responses by a Toll-like receptor-mediated enhancement of the MKP-IRF3 axis. Negishi H, Matsuki K, Endo N, Sarashina H, Miki S, Matsuda A, Fukazawa K, Taguchi-Atarashi N, Ikushima H, Yanai H, Nishio J, Honda K, Fujioka Y, Ohba Y, Noda T, Taniguchi S, Nishida E, Zhang Y, Chi H, Flavell RA, Taniguchi T.Proc. Natl. Acad. Sci. U.S.A. 2013 Dec 03;110(49):19884-9. doi: 10.1073/pnas.1320145110
- 2013.11.13 Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Haferlach T, Nagata Y, Grossmann V, Okuno Y, Bacher U, Nagae G, Schnittger S, Sanada M, Kon A, Alpermann T, Yoshida K, Roller A, Nadarajah N, Shiraishi Y, Shiozawa Y, Chiba K, Tanaka H, Koeffler HP, Klein HU, Dugas M, Aburatani H, Kohlmann A, Miyano S, Haferlach C, Kern W, Ogawa S.Leukemia. 2014 Feb;28(2):241-7. doi: 10.1038/leu.2013.336
- 2013.11.12 Construction and characterization of functional anti-epiregulin humanized monoclonal antibodies. Lee YH, Iijima M, Kado Y, Mizohata E, Inoue T, Sugiyama A, Doi H, Shibasaki Y, Kodama T.Biochem. Biophys. Res. Commun. 2013 Nov 29;441(4):1011-7. doi: 10.1016/j.bbrc.2013.11.014
- 2013.11.11 Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. Muto T, Sashida G, Oshima M, Wendt GR, Mochizuki-Kashio M, Nagata Y, Sanada M, Miyagi S, Saraya A, Kamio A, Nagae G, Nakaseko C, Yokote K, Shimoda K, Koseki H, Suzuki Y, Sugano S, Aburatani H, Ogawa S, Iwama A.J. Exp. Med. 2013 Nov 18;210(12):2627-39. doi: 10.1084/jem.20131144
- 2013.11.08 Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer. Goda S, Isagawa T, Chikaoka Y, Kawamura T, Aburatani H.J. Biol. Chem. 2013 Dec 27;288(52):36948-56. doi: 10.1074/jbc.M113.492595
CLOSE